Cencora U. S. Healthcare Solutions — Revenue decreased by 9.8% to $68.77B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 0.7%, from $68.28B to $68.77B. Over 4 years (FY 2021 to FY 2025), U. S. Healthcare Solutions — Revenue shows a downward trend with a -4.7% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Higher revenue indicates increased market share or higher demand for pharmaceutical products.
The total gross sales generated by the U.S. Healthcare Solutions segment from the distribution of pharmaceuticals and re...
The primary benchmark for scale among pharmaceutical wholesalers.
cor_segment_u_s_healthcare_solutions_revenue| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $50.38B | $202.46B | $52.98B | $50.94B | $53.39B | $212.10B | $56.24B | $56.69B | $59.90B | $61.93B | $65.18B | $61.29B | $67.19B | $71.67B | $74.03B | $68.28B | $72.88B | $75.79B | $76.21B | $68.77B |
| QoQ Change | — | +301.9% | -73.8% | -3.8% | +4.8% | +297.3% | -73.5% | +0.8% | +5.7% | +3.4% | +5.3% | -6.0% | +9.6% | +6.7% | +3.3% | -7.8% | +6.7% | +4.0% | +0.6% | -9.8% |
| YoY Change | — | — | — | — | +6.0% | +4.8% | +6.1% | +11.3% | +12.2% | -70.8% | +15.9% | +8.1% | +12.2% | +15.7% | +13.6% | +11.4% | +8.5% | +5.7% | +2.9% | +0.7% |